Detalhe da pesquisa
1.
Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.
Br J Haematol
; 202(4): 776-784, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386877
2.
Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier.
Blood
; 135(13): 996-1007, 2020 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31977002
3.
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study.
Haematologica
; 107(11): 2675-2684, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35320921
4.
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas.
Blood
; 133(22): 2401-2412, 2019 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30975638
5.
Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients.
Ann Hematol
; 100(4): 1023-1029, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32367180
6.
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study.
Br J Haematol
; 188(5): 661-673, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31573078
7.
Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression.
Br J Haematol
; 189(6): 1064-1073, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32130737
8.
RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group.
Ann Hematol
; 99(4): 799-808, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32076827
9.
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial.
Lancet
; 391(10121): 659-667, 2018 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29241979
10.
Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors.
Haematologica
; 109(1): 343-350, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470152
11.
Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma.
Haematologica
; 104(9): 1822-1829, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30733272
12.
Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia.
J Pathol
; 245(1): 61-73, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29464716
13.
Update on posttransplant lymphoproliferative disease.
Curr Opin Nephrol Hypertens
; 27(6): 440-444, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30157079
14.
Targeting the anion exchanger 2 with specific peptides as a new therapeutic approach in B lymphoid neoplasms.
Haematologica
; 103(6): 1065-1072, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29191842
15.
Post-transplant lymphoproliferative disease after liver transplantation.
Rev Esp Enferm Dig
; 110(2): 131-132, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29313699
16.
Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO).
Haematologica
; 102(2): 235-245, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27846613
17.
First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study.
Eur J Haematol
; 98(1): 38-43, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27232286
18.
HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma.
Blood
; 122(8): 1448-54, 2013 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23843497
19.
Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.
Br J Haematol
; 167(3): 327-36, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25066542
20.
Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma.
Blood
; 130(15): 1772-1774, 2017 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28801448